Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Implementation of Telemedicine in Inflammatory Conditions: A Quality Improvement RFP
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology Canada, USA
    ADVANCE: Global Awards for Advancing Chronic Pain Research
    Release Date:
    Partner: Eli Lilly and Company
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Improving Disparities in Ulcerative Colitis Health Care in Post COVID-19 Era
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology United Kingdom
    New Guidelines for Immuno-therapy in Urothelial Carcinoma (UC)
    Release Date:
    Partner: Merck KGaA Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology France, Germany, Italy, Spain, USA, United Kingdom
    Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    PARP-inhibitor Combination Treatments in Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Remote Mentoring Programs in RCC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality of Care Improvement in Metastatic Breast Cancer Patients (Europe)
    Release Date:
    Partner: The Sharing Progress in Cancer Care (SPCC)
    Review Process: Expert Review Panel
    Quality Improvement Oncology All
    NSCLC Oncogene Driver Considerations in Testing & Treatment
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Identifying and Diagnosing polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology Canada, USA
    Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Unmet Need and Burden of Disease in Moderate-to-Severe Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology France, Germany